Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Platelet function and thrombotic risk in hypopituitarism on hormone replacement therapy
2005-005613-38Phase 4Completed
- Sponsor
- Dr. Chris Thompson
- Start
- Jan 2006
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4 trial of somatropin in hypopituitarism (2 arms), sponsored by Dr. Chris Thompson. Primary endpoint: Percentage change in platelet aggregation. Started Jan 2006; status: completed.
02
Drugs
somatropin
03
Conditions
hypopituitarism
Beyond the preview
Go deeper on 2005-005613-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005613-38.